LENSAR, Inc., headquartered in Orlando, Florida with 110 employees, specializes in femtosecond laser technology for refractive cataract surgery, launching its IPO in 2020. The company offers the LENSAR Laser System and the ALLY Adaptive Cataract Treatment System, enhancing surgical outcomes with proprietary technologies.
LNSR filed a patent for "display screen with graphical user interface for a laser-phacoemulsification system" on Mon, January 9, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.